Lazarus syndrome with crizotinib in a non-small-cell lung cancer patient with ROS1 rearrangement and disseminated intravascular coagulation

Lung cancer is the solid-tumor cancer most frequently diagnosed among patients admitted to the intensive care unit (ICU) with acute respiratory distress syndrome (ARDS) possibly due to its high prevalence (1–3). Despite recent improvement in management of patients presenting with advanced-stage lung cancer in ICUs, short-term survival of such patients proves to be poor, especially for those requiring mechanical ventilation.(1,2,4) That said, intensive care should not be considered futile in these patients, as their outcome may in fact be better than previously reported (5).

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vuQL37
via IFTTT